Recently it has been reported [22] that Epigallocatechin Gallate (EGCG) enhances the sensitivity of colorectal cancer cells to 5FU by Inhibiting GRP78/NF-κB/miR-155- 5p/MDR1 pathway. The gene discussed is NFKB1; the disease is colorectal cancer.